These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2074245

  • 1. Efficacy and tolerance of cefodizime in the treatment of acute pyelonephritis.
    Kourilsky O.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():111-6. PubMed ID: 2074245
    [Abstract] [Full Text] [Related]

  • 2. An open multicentre study of the efficacy and tolerance of cefodizime 1 g bd intravenously or intramuscularly in lower respiratory tract infections.
    Sollet JP.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():103-10. PubMed ID: 2074244
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis].
    Weissbach L, Segal A, Tröster K.
    Infection; 1990 Nov; 18 Suppl 3():S140-4. PubMed ID: 2079374
    [Abstract] [Full Text] [Related]

  • 4. Clinical safety profile of cefodizime.
    Perianu MR.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():127-34. PubMed ID: 2074247
    [Abstract] [Full Text] [Related]

  • 5. A randomized, dose comparison study of cefodizime in the treatment of lower urinary tract infections in women.
    Asbach HW.
    Infection; 1991 Nov; 19(2):85-7. PubMed ID: 2050425
    [Abstract] [Full Text] [Related]

  • 6. Cefodizime: the Japanese clinical experience.
    Matsumoto K.
    Infection; 1992 Nov; 20 Suppl 1():S31-5. PubMed ID: 1526674
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of cefmenoxime in urinary tract and prostatic infections].
    Guibert J, Acar JF, Destree D, Bryskier A.
    Pathol Biol (Paris); 1985 May; 33(5):330-4. PubMed ID: 3897962
    [Abstract] [Full Text] [Related]

  • 11. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
    Maesen FP, Davies BI, van den Bergh JJ, Gubbelmans HL, Meek JC, Geraedts WH.
    J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetic and clinical studies on cefodizime in the pediatric field. Pediatric Study Group of Cefodizime].
    Fujii R, Arimasu O, Meguro H, Hiruma F, Sugie N, Abe T, Nakazawa S, Sato H, Narita A, Matsumoto K.
    Jpn J Antibiot; 1989 May; 42(5):1173-93. PubMed ID: 2664256
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections.
    Newton ER, Yeomans ER, Pastorek JG, Soper DE, Hemsell DL.
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():195-204. PubMed ID: 8150763
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Barradell LB, Brogden RN.
    Drugs; 1992 Nov; 44(5):800-34. PubMed ID: 1280568
    [Abstract] [Full Text] [Related]

  • 19. Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
    Palombini BC, André-Alves MR, Dagrosa EE.
    Arzneimittelforschung; 1997 Mar; 47(3):299-302. PubMed ID: 9105549
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.